基于SWOT分析法的我国中药企业发展策略分析

中医药作为我国独特的卫生资源、潜力巨大的经济资源、具有原创优势的科技资源、优秀的文化资源和重要的生态资源,近年来在我国经济社会发展中成绩斐然。然而也要看到,改革发展中的中医药仍存在诸多问题,尤其是中药企业普遍研发创新意愿不足、研发成果转化能力差、长期小众化发展、中医药全球化水平不高等,这些问题都严重制约了我国中医药的健康全面发展。笔者以我国中药企业为研究对象,运用SWOT分析法对其优势、劣势、机遇和风险进行综合战略分析,得出我国中药企业应将经典名方复方制剂作为产品研发重点,进行中药产品研发创新,并提出产品研发创新的策略。

Research on Development Strategies of Traditional Chinese Medicine Enterprises Based on SWOT Analysis

Traditional Chinese medicine (TCM), as the unique health resources, huge potential economic resources, scientific and technological resources with original advantages, excellent cultural resources and important ecological resources, has made remarkable achievements in Chinese economic and social development in recent years. However, there are still some problems in the reform and development of TCM, especially the lack of willingness to innovate and low ability in commercialization of research and development findings in such companies. Meanwhile, the globalization level of TCM is not high. All these problems have seriously restricted the overall development of TCM. Taking TCM enterprises as the research object, this paper uses SWOT analysis to carry out comprehensive strategic analysis on its advantages, disadvantages, opportunities and risks. It is concluded that TCM enterprises in China should focus on research and development of classical formula compound preparations and innovative TCM products, and then propose product development and innovation strategies.